AUG 10, 2026 · JOURNAL ARTICLE
Early On-Treatment Host Fitness Dynamics Refine Prognostic Stratification in Advanced NSCLC Receiving First-Line Immunotherapy
Cancer Research and Treatment
Prospective multicenter trial of 441 patients shows early on-treatment PNI refines prognosis in advanced NSCLC on immunotherapy with statistically significant associations for PFS and OS, but uses a surrogate nutritional biomarker rather than direct clinical intervention.
Reported
Sample size (paired measurements)441
PNI cutoff50.5
6-month response maintenance OR (…0.40